Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-08-29 00:00:00 ET · period of report 2022-08-25 · accession 0001209191-22-047903 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-29 | 2022-08-25+ | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +36.0K | 59.8K | +151% | +$192.6K |
| DM | 2022-08-29 | 2022-08-25+ | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $28.00 | -36.0K | 42.2K | -46% | -$1.01M |
| DM | 2022-08-29 | 2022-08-25+ | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $0.00 | -36.0K | 457.6K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-26 | M | A | 1,295 | $5.35 | 43,482 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-25 | M | A | 17,052 | $5.35 | 59,239 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-25 | S | D | 17,052 | $28.00 | 42,187 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-29 | S | D | 17,653 | $28.00 | 42,187 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-26 | S | D | 1,295 | $28.00 | 42,187 | D | — | — | |
| 6 | Common | Common Stock | 2022-08-29 | M | A | 17,653 | $5.35 | 59,840 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2022-08-26 | M | D | 1,295 | $0.00 | 475,271 | D | $5.35 · — to 2030-05-11 | 1,295 Common Stock | (F2) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |
| 8 | Derivative | Stock Option (right to buy) | 2022-08-25 | M | D | 17,052 | $0.00 | 476,566 | D | $5.35 · — to 2030-05-11 | 17,052 Common Stock | (F2) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |
| 9 | Derivative | Stock Option (right to buy) | 2022-08-29 | M | D | 17,653 | $0.00 | 457,618 | D | $5.35 · — to 2030-05-11 | 17,653 Common Stock | (F2) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |